Literature DB >> 16827798

Circadian gene mPer2 overexpression induces cancer cell apoptosis.

Hui Hua1, Yueqi Wang, Chaomin Wan, Yanyou Liu, Bin Zhu, Chunlei Yang, Xiaojia Wang, Zhengrong Wang, Germaine Cornelissen-Guillaume, Franz Halberg.   

Abstract

The Period2 gene, an indispensable component of the circadian clock, not only modulates circadian oscillations, but also regulates organic function. We examined whether overexpression of the mouse Period2 gene (mPer2) in tumor cells influences cell growth and induces apoptosis. Overexpression of PERIOD2 in the mouse Lewis lung carcinoma cell line (LLC) and mammary carcinoma cell line (EMT6) results in reduced cellular proliferation and rapid apoptosis, but not in NIH 3T3 cells. Overexpressed mPER2 also altered the expression of apoptosis-related genes. The mRNA and protein levels of c-Myc, Bcl-X(L) and Bcl-2 were downregulated, whereas the expression of p53 and bax was upregulated in mPER2-overexpressing LLC cells compared with control cells transferred with empty plasmid. Our results suggest that the circadian gene mPeriod2 may play an important role in tumor suppression by inducing apoptotic cell death, which is attributable to enhanced pro-apoptotis signaling and attenuated anti-apoptosis processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827798      PMCID: PMC2662332          DOI: 10.1111/j.1349-7006.2006.00225.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  30 in total

1.  Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators.

Authors:  N Le Minh; F Damiola; F Tronche; G Schütz; U Schibler
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus.

Authors:  Ruth A Akhtar; Akhilesh B Reddy; Elizabeth S Maywood; Jonathan D Clayton; Verdun M King; Andrew G Smith; Timothy W Gant; Michael H Hastings; Charalambos P Kyriacou
Journal:  Curr Biol       Date:  2002-04-02       Impact factor: 10.834

3.  Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells.

Authors:  Giles E Duffield; Jonathan D Best; Bernhard H Meurers; Anton Bittner; Jennifer J Loros; Jay C Dunlap
Journal:  Curr Biol       Date:  2002-04-02       Impact factor: 10.834

4.  Coordinated transcription of key pathways in the mouse by the circadian clock.

Authors:  Satchidananda Panda; Marina P Antoch; Brooke H Miller; Andrew I Su; Andrew B Schook; Marty Straume; Peter G Schultz; Steve A Kay; Joseph S Takahashi; John B Hogenesch
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

5.  Extensive and divergent circadian gene expression in liver and heart.

Authors:  Kai-Florian Storch; Ovidiu Lipan; Igor Leykin; N Viswanathan; Fred C Davis; Wing H Wong; Charles J Weitz
Journal:  Nature       Date:  2002-04-21       Impact factor: 49.962

Review 6.  Coordination of circadian timing in mammals.

Authors:  Steven M Reppert; David R Weaver
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

7.  Circadian clock and microarrays: mammalian genome gets rhythm.

Authors:  Franck Delaunay; Vincent Laudet
Journal:  Trends Genet       Date:  2002-12       Impact factor: 11.639

Review 8.  The Bcl2 family: regulators of the cellular life-or-death switch.

Authors:  Suzanne Cory; Jerry M Adams
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

9.  Host circadian clock as a control point in tumor progression.

Authors:  Elisabeth Filipski; Verdun M King; XiaoMei Li; Teresa G Granda; Marie-Christine Mormont; XuHui Liu; Bruno Claustrat; Michael H Hastings; Francis Lévi
Journal:  J Natl Cancer Inst       Date:  2002-05-01       Impact factor: 13.506

10.  The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.

Authors:  Loning Fu; Helene Pelicano; Jinsong Liu; Peng Huang; Cheng Lee
Journal:  Cell       Date:  2002-10-04       Impact factor: 41.582

View more
  77 in total

1.  PML regulates PER2 nuclear localization and circadian function.

Authors:  Takao Miki; Zhixiang Xu; Misty Chen-Goodspeed; Mingguang Liu; Anita Van Oort-Jansen; Michael A Rea; Zhaoyang Zhao; Cheng Chi Lee; Kun-Sang Chang
Journal:  EMBO J       Date:  2012-01-24       Impact factor: 11.598

Review 2.  Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies.

Authors:  Lara G Sigurdardottir; Unnur A Valdimarsdottir; Katja Fall; Jennifer R Rider; Steven W Lockley; Eva Schernhammer; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

3.  The role of circadian rhythm in breast cancer.

Authors:  Shujing Li; Xiang Ao; Huijian Wu
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

4.  Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia.

Authors:  Sobia Rana; Mustafa Munawar; Adeela Shahid; Meera Malik; Hafeez Ullah; Warda Fatima; Shahida Mohsin; Saqib Mahmood
Journal:  Mol Biol Rep       Date:  2013-11-05       Impact factor: 2.316

5.  Nucleolar localization and circadian regulation of Per2S, a novel splicing variant of the Period 2 gene.

Authors:  Daniele Avitabile; Licia Genovese; Donatella Ponti; Danilo Ranieri; Salvatore Raffa; Antonella Calogero; Maria Rosaria Torrisi
Journal:  Cell Mol Life Sci       Date:  2013-11-08       Impact factor: 9.261

6.  Adverse effects of chronic circadian desynchronization in animals in a "challenging" environment.

Authors:  Fabian Preuss; Yueming Tang; Aaron D Laposky; Deanna Arble; Ali Keshavarzian; Fred W Turek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-08       Impact factor: 3.619

7.  Sleep disruption among older men and risk of prostate cancer.

Authors:  Lara G Sigurdardottir; Unnur A Valdimarsdottir; Lorelei A Mucci; Katja Fall; Jennifer R Rider; Eva Schernhammer; Charles A Czeisler; Lenore Launer; Tamara Harris; Meir J Stampfer; Vilmundur Gudnason; Steven W Lockley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05       Impact factor: 4.254

8.  Neuroprotective role of the basic leucine zipper transcription factor NFIL3 in models of amyotrophic lateral sclerosis.

Authors:  So-ichi Tamai; Keisuke Imaizumi; Nobuhiro Kurabayashi; Minh Dang Nguyen; Takaya Abe; Masatoshi Inoue; Yoshitaka Fukada; Kamon Sanada
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

9.  The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response.

Authors:  Aaron E Hoffman; Tongzhang Zheng; Yue Ba; Yong Zhu
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

10.  Per2 inhibits k562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction.

Authors:  Cheng-ming Sun; Shi-feng Huang; Jian-ming Zeng; Din-bing Liu; Qing Xiao; Wen-jun Tian; Xi-dan Zhu; Zong-gan Huang; Wen-li Feng
Journal:  Pathol Oncol Res       Date:  2009-12-03       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.